Home > Insider Trading > Filing (0001144204-18-062675)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Fortress Biotech Inc.	FBIO	Pharmaceutical Preparations (2834)	205157386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1713932	Robyn Hunter	C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-11-23	20,370	$1.29	239,759	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

In connection with the vesting of 62,500 shares on November 20, 2018, a total of 20,370 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 23, 2018, was $1.28 to $1.34. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 239,759 shares, 187,500 shares are restricted stock units.